BACKGROUND: Frequent idiopathic premature ventricular complexes (PVC) are associated with a reversible form of cardiomyopathy. The effect of frequent PVCs on left ventricular function has not been evaluated in post-infarction patients. OBJECTIVE: This study sought to evaluate the value of post-infarction PVC ablation and possible determinants of a reversible cardiomyopathy. METHODS: Thirty consecutive patients (24 men, age 61 +/- 12, left ventricular ejection fraction [LVEF] 0.36 +/- 0.12) with remote myocardial infarction referred for implantable cardioverter-defibrillator (ICD) implantation for primary prevention of sudden death or for management of symptomatic ventricular tachycardia or PVCs were evaluated. Fifteen patients with a high PVC burden (>or=5% of all QRS complexes on 24-h Holter monitor) underwent mapping and ablation of PVCs before ICD implantation. The remaining 15 patients served as a control group. LVEF was assessed by echocardiography, and scar burden was assessed by cardiac magnetic resonance imaging with delayed enhancement (DE-MRI) in both groups. RESULTS: PVC ablation was successful in 15 of 15 patients and reduced the mean PVC burden from 22 +/- 12% to 2.6 +/- 5.0% (P <.001). After the procedure, LVEF increased significantly from 0.38 +/- 0.11 to 0.51 +/- 0.09 in the PVC ablation group (P = .0001). In the control group, LVEF remained unchanged within the same time frame (0.34 +/- 0.14 vs. 0.33 +/- 0.15; P = .6). Patients with frequent PVCs had a significantly smaller scar burden by DE-MRI compared with control patients. Five of the patients with frequent PVCs underwent ICD implantation. CONCLUSION: Post-infarction patients with frequent PVCs may have a reversible form of cardiomyopathy. DE-MRI may identify patients in whom the LVEF may improve after ablation of frequent PVCs.
BACKGROUND: Frequent idiopathic premature ventricular complexes (PVC) are associated with a reversible form of cardiomyopathy. The effect of frequent PVCs on left ventricular function has not been evaluated in post-infarctionpatients. OBJECTIVE: This study sought to evaluate the value of post-infarction PVC ablation and possible determinants of a reversible cardiomyopathy. METHODS: Thirty consecutive patients (24 men, age 61 +/- 12, left ventricular ejection fraction [LVEF] 0.36 +/- 0.12) with remote myocardial infarction referred for implantable cardioverter-defibrillator (ICD) implantation for primary prevention of sudden death or for management of symptomatic ventricular tachycardia or PVCs were evaluated. Fifteen patients with a high PVC burden (>or=5% of all QRS complexes on 24-h Holter monitor) underwent mapping and ablation of PVCs before ICD implantation. The remaining 15 patients served as a control group. LVEF was assessed by echocardiography, and scar burden was assessed by cardiac magnetic resonance imaging with delayed enhancement (DE-MRI) in both groups. RESULTS: PVC ablation was successful in 15 of 15 patients and reduced the mean PVC burden from 22 +/- 12% to 2.6 +/- 5.0% (P <.001). After the procedure, LVEF increased significantly from 0.38 +/- 0.11 to 0.51 +/- 0.09 in the PVC ablation group (P = .0001). In the control group, LVEF remained unchanged within the same time frame (0.34 +/- 0.14 vs. 0.33 +/- 0.15; P = .6). Patients with frequent PVCs had a significantly smaller scar burden by DE-MRI compared with control patients. Five of the patients with frequent PVCs underwent ICD implantation. CONCLUSION: Post-infarctionpatients with frequent PVCs may have a reversible form of cardiomyopathy. DE-MRI may identify patients in whom the LVEF may improve after ablation of frequent PVCs.
Authors: R Goyal; M Harvey; E G Daoud; K Brinkman; B P Knight; M Bahu; R Weiss; F Bogun; K C Man; S A Strickberger; F Morady Journal: Circulation Date: 1996-12-01 Impact factor: 29.690
Authors: O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd Journal: Radiology Date: 2001-01 Impact factor: 11.105
Authors: H L Kennedy; J A Whitlock; M K Sprague; L J Kennedy; T A Buckingham; R J Goldberg Journal: N Engl J Med Date: 1985-01-24 Impact factor: 91.245
Authors: J S Shinbane; M A Wood; D N Jensen; K A Ellenbogen; A P Fitzpatrick; M M Scheinman Journal: J Am Coll Cardiol Date: 1997-03-15 Impact factor: 24.094
Authors: Luciano C Amado; Bernhard L Gerber; Sandeep N Gupta; Dan W Rettmann; Gilberto Szarf; Robert Schock; Khurram Nasir; Dara L Kraitchman; João A C Lima Journal: J Am Coll Cardiol Date: 2004-12-21 Impact factor: 24.094
Authors: R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd Journal: N Engl J Med Date: 2000-11-16 Impact factor: 91.245
Authors: Ravi K Yarlagadda; Sei Iwai; Kenneth M Stein; Steven M Markowitz; Bindi K Shah; Jim W Cheung; Vivian Tan; Bruce B Lerman; Suneet Mittal Journal: Circulation Date: 2005-08-15 Impact factor: 29.690
Authors: Benoit Desjardins; Thomas Crawford; Eric Good; Hakan Oral; Aman Chugh; Frank Pelosi; Fred Morady; Frank Bogun Journal: Heart Rhythm Date: 2009-02-14 Impact factor: 6.343
Authors: J D Hummel; S A Strickberger; E Daoud; M Niebauer; O Bakr; K C Man; B D Williamson; F Morady Journal: Circulation Date: 1994-12 Impact factor: 29.690
Authors: Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld Journal: J Interv Card Electrophysiol Date: 2020-10 Impact factor: 1.900
Authors: Jose F Huizar; Karoly Kaszala; Jonathan Potfay; Anthony J Minisi; Edward J Lesnefsky; Antonio Abbate; Eleonora Mezzaroma; Qun Chen; Rakesh C Kukreja; Nicholas N Hoke; Leroy R Thacker; Kenneth A Ellenbogen; Mark A Wood Journal: Circ Arrhythm Electrophysiol Date: 2011-05-16
Authors: J Fedida; T Strisciuglio; M Sohal; M Wolf; K Van Beeumen; A Neyrinck; P Taghji; C Lepiece; A Almorad; Y Vandekerckhove; R Tavernier; M Duytschaever; S Knecht Journal: J Interv Card Electrophysiol Date: 2018-02-24 Impact factor: 1.900